The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Zofran 8mg/4ml Solution for Injection or Infusion

Novartis Ireland LimitedPA0896/036/002

Main Information

Trade NameZofran 8mg/4ml Solution for Injection or Infusion
Active SubstancesOndansetron hydrochloride dihydrate
Dosage FormSolution for injection/infusion
Licence HolderNovartis Ireland Limited
Licence NumberPA0896/036/002

Group Information

ATC CodeA04AA Serotonin (5HT3) antagonists
A04AA01 ondansetron


License statusWithdrawn
Withdrawn Date31/12/2023
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusMarketed


Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back